NewsBenzingaAgenus Announces New Findings From Long-Term Survivor Analysis Of Phase 1b C-800-01 Trial Evaluating Botensilimab In Combination With Balstilimab In Heavily Pretreated Patients With MSS, mCRC Without Active Liver Metastases Agenus Announces New Findings From Long-Term Survivor Analysis Of Phase 1b C-800-01 Trial Evaluating Botensilimab In Combination With Balstilimab In Heavily Pretreated Patients With MSS, mCRC Without Active Liver Metastases Benzinga 2026.11.06 14:04 (GMT+0) Open on Benzinga Other news NVIDIA Interim CEO Colette Kress Says Vera Rubin Is Off To An Explosive Start, Our Roadmap Is On Track And Our Ambition Has Never Been Greater Here’s How Much You Would Have Made Owning Marvell Technology Stock In The Last 20 Years NVIDIA Sees Q4 Sales $126.100B-$133.900B vs $125.163B Est NVIDIA Q3 Adj. EPS $2.68 Beats $2.48 Estimate, Sales $115.844B Beat $109.080B Estimate Dolby Laboratories Sees Q1 GAAP EPS $0.01-$0.16 vs $0.76 Est Dolby Laboratories Sees Q1 Adj EPS $0.41-$0.56 vs $1.12 Est; Sees Sales $285.000M-$305.000M vs $359.329M Est
NVIDIA Interim CEO Colette Kress Says Vera Rubin Is Off To An Explosive Start, Our Roadmap Is On Track And Our Ambition Has Never Been Greater
Dolby Laboratories Sees Q1 Adj EPS $0.41-$0.56 vs $1.12 Est; Sees Sales $285.000M-$305.000M vs $359.329M Est